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Pathophysiology of Pompe’s disease
RARE CASE OF ADULT ONSET POMPE’S DISEASE IN A PATIENT WITH TYPE 1 
DIABETES MELLITUS
Supriya Todkar, Mahalakshmi Honasoge
Endocrinology , Diabetes and Metabolism 
Henry Ford Health System, Detroit, Michigan 
• Late-onset Pompe’s disease is a rare, progressive,
autosomal recessive disorder; disease progression
and symptomatology are variable between
individuals, which delays the diagnosis.
• Use of ERT has substantially altered outcomes for
the patients, underscoring the importance of early
diagnosis with high index of suspicion.
• Additional impact of type 1 DM is of concern in
our patient.
• Since glycogen hepatopathy is associated with
uncontrolled Type 1 DM, tight control of diabetes
may help to reduce the impact of acid alpha
glucosidase deficiency.
• Improvement of bone density after ERT suggests
need for further studies to elucidate the
pathophysiology of bone involvement in this
disorder.
•Pompe’s disease is a lysosomal storage disease
characterized by accumulation of glycogen primarily
in muscle tissue.
• Infantile and late onset are the two common forms of
this disease.
•We present a case of adult onset disease in a patient
with type 1 diabetes mellitus (DM) with involvement
of muscle, liver and bone.
•A 28-year-old male was being followed up for type 1
diabetes mellitus. He had a long standing history of
mild muscle weakness.
• Family history : Unknown muscle disorder in father
and cardiomyopathy in grandfather.
•Previous work up showed elevated CPK levels of
1340 (reference range < 130IU/L) along with
elevated transaminases.
•Muscle biopsy - Autophagic activity producing
rimmed vacuole like structures in many of the
muscle fibers, with increased staining of cytoplasm
with Periodic acid Schiff.
•He was lost to follow up and about 10 years later
decided to undergo further evaluation , which
showed persistently elevated CPK levels.
•EMG studies which showed generalized myopathic
process.
•Serum acid maltase level was found to be low.
•On Glucosidase aide alpha gene sequencing, he was
found to have c.-32-13T>G and c.1655T>C (p.
L552P) mutation.
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